Highlights
NASDAQ: AFMD       Affimed N.V.
Last Price Today's Change   Day's Range   Trading Volume
6.19   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):804,300
4 Weeks Range:5.61 - 6.23
4 Weeks Price Volatility (%):
99.36%
52 Weeks Range:3.085 - 11.74
52 Weeks Price Volatility (%):
52.73%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. It is also developing single and combination therapies to treat cancers and other life-threatening diseases. The company generates its pipeline of product candidates from several proprietary platform technologies NK-cell and T-cell TandAbs, tri specific Abs and alternative antibody formats. The company's operations are located in Germany, Europe, and the USA.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1444  2970  178  6898 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TLGT 0.174-0.028 
 BKKT 23.82-6.78 
 RPAI 13.15-0.43 
 TSLA 1,013.00-11.86 
 NIO 40.625-0.645 
 FB 312.09-16.60 
 PLTR 25.595+0.185 
 F 15.735-0.265 
 AMD 123.293+0.933 
 INTC 48.005-1.405